Abstract:The 17th century London neuroanatomical school headed by Thomas Willis provided us with the first identifiable images of the sympathetic nervous system. Nineteenth century giants of European physiology (Bernard, Waller and Brown-Sequard) identified these as the 'pressor nerves'. Von Euler's demonstration that the sympathetic transmitter was noradrenaline brought the field into the modern era. The development of ganglion-blocking drugs by Paton, whose name this review commemorates, allowed comprehensive pharmacological antagonism of this system in patients. With the development of contemporary techniques for recording from human sympathetic nerves and quantifying rates of noradrenaline release, the sympathetic nervous system became accessible to clinical scientists investigating possible contributions to cardiovascular and other diseases. Sympathetic nervous system responses typically are regionally differentiated, with activation in one outflow sometimes accompanying no change or sympathetic inhibition in another. Regional sympathetic activity is best studied in humans by recording from postganglionic sympathetic efferents (multi-unit or single-fibre recording) and by isotope dilution-derived measurement of organ-specific noradrenaline release to plasma from sympathetic nerves (regional 'noradrenaline spillover'). With the application of these techniques, evidence has been assembled in the past three decades which indicates that sympathetic nervous system activation is crucial in the development of cardiovascular disorders, most notably heart failure and essential hypertension. An important goal for clinical scientists is translation of knowledge of pathophysiology, such as this, into better treatment for patients. The achievement of this 'mechanisms to management' transition is mature in cardiac failure, with knowledge of cardiac neural pathophysiology having led to introduction of β-adrenergic blockers, an effective therapy. Perhaps we are now on the cusp of effective translation in patients with essential hypertension, with recent successful testing of selective catheter-based renal sympathetic nerve ablation in patients with resistant hypertension, an intervention firmly based on prior demonstration in them of activation of the renal sympathetic outflow.

The Sympathetic Nervous System in Hypertension: Roadmap Update of a Long Journey

Microglia, autonomic nervous system, immunity and hypertension: Is there a link?

The sympathetic nervous system through the ages: from Thomas Willis to resistant hypertension

Sympathetic overactivity, hypertension and cardiovascular disease: state of the art

Role of the Sympathetic Nervous System and Its Modulation in Renal Hypertension

The role of the sympathetic nervous system in resistant hypertension: pathophysiological and clinical aspects

The road to renal denervation for hypertension and beyond (HF): two decades of failed, succeeded, and to be determined

Sympathetic overactivity as a cause of hypertension in chronic renal failure

Sympathetic activation in congestive heart failure: an updated overview

The bidirectional interaction between the sympathetic nervous system and immune mechanisms in the pathogenesis of hypertension

The Sympathetic Nervous System in Hypertensive Heart Failure with Preserved LVEF

Autonomic nervous system activity changes in patients with hypertension and overweight: role and therapeutic implications

The crosstalk between the kidney and the central nervous system: the role of renal nerves in blood pressure regulation

The sympathetic nervous system in heart failure revisited

Disorders of Blood Pressure Regulation—Role of Catecholamine Biosynthesis, Release, and Metabolism

Pathophysiologic Mechanisms in Heart Failure: Role of the Sympathetic Nervous System

Renal sympathetic nerves - what have they got to do with cardiovascular disease?

Obesity-Related Metabolic Syndrome: Mechanisms of Sympathetic Overactivity

Contribution of Autonomic Reflexes to the Hyperadrenergic State in Heart Failure

Refractory arterial hypertension: hyperactivity of the sympathetic nervous system, kidney and approaches to antihypertensive drug therapy

Emerging topics on basic research in hypertension: interorgan communication and the need for interresearcher collaboration